Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood products used in cirrhosis with Non-variceal Bleeding
Phase 2
- Conditions
- Health Condition 1: K769- Liver disease, unspecified
- Registration Number
- CTRI/2023/12/060804
- Lead Sponsor
- Institute of Liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with Cirrhosis of any etiology
2.Age between 18 and 80 years;
3.Presenting with nonvariceal upper GI bleeding (diagnosed after doing upper GI endoscopy, which showed ongoing
4.bleed form a nonvariceal source); and
5.Significant coagulopathy assessed by CCTs (INR > 1.8 and/or PLTs < 50 × 109/L).
Exclusion Criteria
1.Variceal bleed
2.Post Variceal ligation ulcer bleed
3.Previous or current thrombotic events defined as any documented blood clot in a venous or arterial vessel;
4.Anti-PLT or anticoagulant therapy at the time of enrollment or that had been discontinued less than 7 days before evaluation for the study;
5.Pregnancy
6.Significant cardiopulmonary diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method